Publications by authors named "Isabelle Riviere"

Claim this Profile
I
iPSC-derived T cells and macrophages: Manufacturing and next-generation application approaches.
Débora Basílio-Queirós, Isabelle Rivière, Sjoukje J C van der Stegen, Nico Lachmann

Adv Drug Deliv Rev· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming barriers to commercially pre-viable gene and cell therapies for rare and ultra-rare diseases.
David Barrett, Paula M Cannon, Federico Mingozzi, Matthew Porteus, Isabelle Rivière

Mol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma.
Jae H Park, M Lia Palomba, Karlo Perica, Sean M Devlin, Gunjan Shah

J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies.
Sanam Shahid, Susan E Prockop, Georgia C Flynn, Audrey Mauguen, Charlie O White

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis.
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, Kinga Hosszu, Sean M Devlin

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells.
Sjoukje J C van der Stegen, Pieter L Lindenbergh, Roseanna M Petrovic, Hongyao Xie, Mame P Diop, Isabelle Riviere

Nat Biomed Eng· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma.
Jae Park, M Lia Palomba, Karlo Perica, Sean Devlin, Gunjan Shah, Isabelle Riviere

Res Sq· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors.
Johannes L Zakrzewski, David Suh, John C Markley, Odette M Smith, Christopher King, Isabelle Riviere

Nat Biotechnol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V Amelsberg, Sean M Devlin, Isabelle Riviere

Nat Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cooperative CAR targeting to selectively eliminate AML and minimize escape.
Sascha Haubner, Jorge Mansilla-Soto, Sarah Nataraj, Friederike Kogel, Qing Chang

Cancer Cell· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology.
Maria E Arcila, Utsav Patel, Amir Momeni-Boroujeni, JinJuan Yao, Roger Chan, Isabelle C Riviere

J Mol Diagn· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.
Jae H Park, Karthik Nath, Sean M Devlin, Craig S Sauter, M Lia Palomba, Isabelle Riviere

Nat Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating.
Mohamad Hamieh, Jorge Mansilla-Soto, Isabelle Rivière, Michel Sadelain

Cancer Discov· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials.
Kenneth Cornetta, Jing Yao, Kimberley House, Lisa Duffy, Prasad S Adusumilli

Mol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling barriers to iPSC-derived CAR-T cell differentiation.
Sjoukje J C van der Stegen, Isabelle Rivière

Cell Stem Cell· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells.
Sjoukje J C van der Stegen, Pieter L Lindenbergh, Roseanna M Petrovic, Hongyao Xie, Mame P Diop, Isabelle Riviere

Nat Biomed Eng· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPRC5D-Targeted CAR T Cells for Myeloma.
Sham Mailankody, Sean M Devlin, Jonathan Landa, Karthik Nath, Claudia Diamonte

N Engl J Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly V Amelsberg, Sean M Devlin, Isabelle Riviere

Nat Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-independent T cell receptors for targeting tumors with low antigen density.
Jorge Mansilla-Soto, Justin Eyquem, Sascha Haubner, Mohamad Hamieh, Judith Feucht

Nat Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience.
M Lia Palomba, David Qualls, Sebastien Monette, Shenon Sethi, Ahmet Dogan

J Immunother Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial.
Farid Boulad, Aurelio Maggio, Xiuyan Wang, Paolo Moi, Santina Acuto

Nat Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab.
Prasad S Adusumilli, Marjorie G Zauderer, Isabelle Rivière, Stephen B Solomon, Valerie W Rusch

Cancer Discov· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T cells: Building on the CD19 paradigm.
Anat Globerson Levin, Isabelle Rivière, Zelig Eshhar, Michel Sadelain

Eur J Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of high-content CD14 cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing.
Xiuyan Wang, Oriana Borquez-Ojeda, Jolanta Stefanski, Fang Du, Jinrong Qu

Mol Ther Methods Clin Dev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy.
Kitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière, Mithat Gönen, Xiuyan Wang

Blood· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis